TELO NASDAQ
Telomir Pharmaceuticals, Inc. Common Stock
1W: -4.1%
1M: +5.4%
3M: -7.1%
YTD: -11.9%
1Y: -15.1%
$1.18
+0.01 (+0.85%)
Weekly Expected Move ±6.7%
$1
$1
$1
$1
$1
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$0M
Revenue
+0.0% YoY
$-6M
Net Income
+63.6% YoY
$-5M
Free Cash Flow
-55.1% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-213.1%
ROA-189.7%
ROIC3515.1%
Valuation
P/E-0.8
P/B8.1
EV/EBITDA-6.6
Leverage
Debt/Equity0.00
Current Ratio16.14
Interest Cov.-837.1x
Quality Scores
Piotroski F4/9
Altman Z65.54
Beneish M0.00